Search for a rare disease
Other search option(s)
Drug-induced localized lipodystrophy
Disease definition
Drug-induced localized lipodystrophy is a rare, acquired, localized lipodystrophy characterized by the appearance of asymptomatic, well-demarcated, variably sized, depressed, lipoatrophic lesions secondary to subcutaneous, intradermic or intramuscular drug injection, including corticosteroids, insulin, human growth hormone and antibiotics. Skin coloration may vary from white or hypopigmented to reddish, pinkish or violaceous. Epidermal atrophy may be also present.
ORPHA:90157
Classification level: Disorder- Synonym(s):
- Lipoatrophy caused by injected drug
- Prevalence: -
- Inheritance: -
- Age of onset: All ages
- ICD-10: E88.1
- ICD-11: EF01.1
- OMIM: -
- UMLS: C1274983
- MeSH: -
- GARD: -
- MedDRA: -
A summary on this disease is available in Deutsch (2018) Español (2018) Français (2018) Italiano (2018) Nederlands (2018) Polski (2019)
Additional information
Further information on this disease
Patient-centred resources for this disease
Research activities on this disease
Specialised Social Services
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.